Hong Kong stock movement: China National Pharmaceutical Group rises 13.47%, $1.9 billion overseas licensing ignites the marketHK Stock Alerts·7 hours ago01177+12.53%
Hong Kong stock movement: China National Pharmaceutical Group rises 18.89%: Half-year net profit doubles, renamed SBP GroupHK Stock Alerts·12 hours ago01177+12.53%
AI isn’t close to curing cancer. This startup says it knows what it will take.TechCrunch·1 day ago, 07:06 AM
Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastasesPUBT·1 day ago, 03:26 AM
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectivesPUBT·2 days ago, 07:55 AMCNXU+7.24%
argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the MovementTradingKey·2 days ago, 11:16 AMARGX+0.02%
U.S. stock night market volatility: FDA restarts review + rating upgrade, Capricor surges 58%Price Alert·Aug 16 at 08:46 PMCAPR-8.15%
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business UpdateUnusual Whales·Aug 14 at 06:01 AM
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) AcceptanceUnusual Whales·Jul 8 at 08:05 AM300363+20.00%
07:08 ETChina-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapyprnewswire·May 28 at 06:10 AM300363+20.00%
